Adial Pharmaceuticals Rebrands as Azora Therapeutics Ahead of Planned Clinical Trial
Adial Pharmaceuticals has officially rebranded as Azora Therapeutics, with Matt Davidson appointed as president and…
Newswire
Vertex Pharmaceuticals Plans New Research Facility at Harwell Science Campus
Vertex Pharmaceuticals plans to establish a 155,000-square-foot research facility at the Harwell Science and Innovation…
EMA Office Closure on All Souls’ Day, 2 November
The European Medicines Agency (EMA) will be closed on Monday, 2 November, in observance of…
UK Budget Light on Life Sciences but More Doors Open for Biotech Startups
In a recent announcement, the UK government unveiled its Autumn Budget, which has drawn a…
Cellares and GenomeFrontier to Assess Automated GF-CART01 Production
Cellares and GenomeFrontier Therapeutics have announced a collaboration to evaluate the automated manufacturing of GF-CART01,…
Viatris’ Wakix Receives Japanese Approval for OSAS and Narcolepsy Treatment
Japan’s Ministry of Health, Labour and Welfare has granted approval for Viatris’ Wakix, a significant…
FDA Identifies New Safety Signals in Adverse Event Monitoring for Q1 2026
During the first quarter of 2026, the FDA’s Adverse Event Monitoring System (AEMS) reported new…
Novartis to pay $125M for blood-brain barrier crossing platform
Novartis has announced a significant investment of $125 million to acquire global rights to a…
GOP Advances Bill to Alter Medicare Adviser’s Analysis Favoring Health Insurers
WASHINGTON — In a notable shift in the legislative landscape, the House Ways and Means…
Loss of Brain Protein in Mice Reveals Mechanisms Behind ADHD
Recent research from the University of Fukui has identified a critical link between the loss…